Newron Pharmaceuticals
NWRN.SW
#8322
Rank
A$0.23 B
Marketcap
$12.38
Share price
-1.10%
Change (1 day)
69.93%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2023: -A$27.54 Million

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are A$10.01 Million. In 2023 the company made an earning of -A$27.54 Million, an increase over its 2022 earnings that were of -A$28.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2023

Annual earnings

Year Earnings Change
2023-A$27.54 Million-4.45%
2022-A$28.82 Million11.19%
2021-A$25.92 Million-30.14%
2020-A$37.11 Million6.84%
2019-A$34.73 Million31.45%
2018-A$26.42 Million170.13%
2017-A$9.78 Million-60.23%
2016-A$24.59 Million-41.46%
2015-A$42.01 Million109.46%
2014-A$20.06 Million22.43%
2013-A$16.38 Million222.49%
2012-A$5.08 Million-60.49%
2011-A$12.86 Million-71%
2010-A$44.33 Million-17.37%
2009-A$53.65 Million52.58%
2008-A$35.16 Million41.24%
2007-A$24.9 Million-25.19%
2006-A$33.28 Million22.45%
2005-A$27.18 Million